Director and Trustee, Healthcare, Life Sciences, and Financial Services
Alison Taunton-Rigby, Ph.D., O.B.E., is an executive, leader, and entrepreneur in the world of healthcare, life sciences and financial services. She has been President and CEO of several public and private biotechnology companies. As an entrepreneur she has successfully founded, built, and financed biotechnology companies, and has led teams that discovered, developed, and introduced several life-saving drugs, many for diseases that affect children. Alison has served as a Director on public, private, college, foundation, non-profit, ESOP and mutual fund boards, and currently sits on the boards of Blumont Inc., TetraGenetics Inc., and Boston Children's Hospital. Alison is a speaker and teacher in demand on wide ranging topics involving life sciences, healthcare, and healthcare reform. She is also active at the state, national and international levels, and has testified before federal congressional committees on issues of drug pricing, regulation, bioethics, and cloning. She is an active mentor to women entrepreneurs through several organizations, including Springboard Enterprises and the International Women’s Forum, and teaches post-graduate courses at Boston area universities. Alison received her doctorate from the University of Bristol in England and is a graduate of the Harvard Business School’s Advanced Management program. She has received a number of awards and honors, including the OBE (Officer of the Order of the British Empire) by Queen Elizabeth II for her work as a leader in the research, development and promotion of biotechnology and a D.Sc. (Honoris Causae) by the University of Bristol.